Clinical Trial Update: Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with bevacizumab in operable breast cancer; trial compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Ian E. Krop, MD, PhD | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-05-10